Miol-P 750mcg/75mg Capsule SR
Marketer
Dr. Johns Laboratories Pvt Ltd
Salt Composition
Methylcobalamin (750mcg) + Pregabalin (75mg)
Overview Miol-P 750mcg/75mg Capsule SR
Neuropathic pain is treated with the prescription medication, Miol-P 750mcg/75mg Extended-Release Capsules. Its mechanism involves modulating nerve cell calcium channel activity to reduce pain, while also safeguarding and repairing nerve fibers. Administered orally, with or without food, ideally before sleep, consistent daily timing ensures stable drug levels. Adherence to the prescribed dosage and duration is crucial, as this medication has addictive potential. Missed doses should be taken promptly upon recall; complete the entire course regardless of symptom improvement. Abrupt discontinuation is unsafe without physician consultation. Common, generally mild and transient, adverse effects include nasal congestion, increased hunger, elevated mood, trembling, visual blurring, dry mouth, vertigo, and somnolence. Avoid tasks demanding concentration until the drug's impact is understood. Weight gain is possible; regular exercise and a healthy diet can mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Full disclosure of all other medications is essential, as interactions may compromise efficacy or alter the drug's action. Disclose pregnancy, pregnancy plans, or breastfeeding to your physician.
Uses of Miol-P 750mcg/75mg Capsule SR
Managing neuropathic pain
Major Benefits of Miol-P 750mcg/75mg Capsule SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 750mcg/75mg Miol-P SR capsule whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent daily timing is recommended.
Common Side effects of Miol-P 750mcg/75mg Capsule SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Miol-P 750mcg/75mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Miol-P 750mcg/75mg sustained-release capsule should be swallowed whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
How Miol-P 750mcg/75mg Capsule SR works:
Miol-P 750mcg/75mg sustained-release capsules contain methylcobalamin and pregabalin. Methylcobalamin, a vitamin B derivative, supports myelin production, shielding nerve fibers and aiding damaged nerve cell repair. Pregabalin, acting as an alpha-2-delta ligand, reduces pain signals by modulating nerve cell calcium channel function. This combined action provides relief from neuropathic pain stemming from nerve damage.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Miol-P 750mcg/75mg sustained-release capsules and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Miol-P 750mcg/75mg capsules might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Miol-P 750mcg/75mg capsule is likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Miol-P 750mcg/75mg sustained-release capsules might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Miol-P 750mcg/75mg sustained-release capsules cautiously. Dosage modification of Miol-P 750mcg/75mg sustained-release capsules may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Miol-P 750mcg/75mg sustained-release capsules in patients with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Miol-P 750mcg/75mg Capsule SR :
Should you forget a dose of Miol-P 750mcg/75mg sustained-release capsules, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Miol-P 750mcg/75mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
3,018 People bought this recently